Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-429X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance ; volume:11 ; number:1 ; day:11 ; month:11 ; year:2009 ; pages:1-5 ; date:12.2009
Journal of cardiovascular magnetic resonance ; 11, Heft 1 (11.11.2009), 1-5, 12.2009
- Urheber
-
Lopez, Javier E.
- Beteiligte Personen und Organisationen
-
Yeo, Khung
Caputo, Gary
Buonocore, Michael
Schaefer, Saul
SpringerLink (Online service)
- DOI
-
10.1186/1532-429X-11-46
- URN
-
urn:nbn:de:1111-2016032155880
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lopez, Javier E.
- Yeo, Khung
- Caputo, Gary
- Buonocore, Michael
- Schaefer, Saul
- SpringerLink (Online service)
Ähnliche Objekte (12)
Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
Report of methamphetamine use and cardiomyopathy in three patients
Cardiovascular magnetic resonance imaging characteristics in patients with methamphetamine-associated cardiomyopathy
Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
Methamphetamine induces cardiomyopathy by Sigmar1 inhibition-dependent impairment of mitochondrial dynamics and function
Sex differences in behavior, cognitive, and physiological recovery following methamphetamine administration
Ventricular arrhythmias in apical hypertrophic cardiomyopathy: association with late gadolinium enhancement
Stress perfusion CMR in hypertrophic cardiomyopathy: comparison with late gadolinium enhancement
Clinical significance of late gadolinium enhancement in pediatric patients with hypertrophic cardiomyopathy
Ringlike late gadolinium enhancement provides incremental prognostic value in non-classical arrhythmogenic cardiomyopathy
Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
Report of methamphetamine use and cardiomyopathy in three patients
Cardiovascular magnetic resonance imaging characteristics in patients with methamphetamine-associated cardiomyopathy
Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
Methamphetamine induces cardiomyopathy by Sigmar1 inhibition-dependent impairment of mitochondrial dynamics and function
Sex differences in behavior, cognitive, and physiological recovery following methamphetamine administration
Ventricular arrhythmias in apical hypertrophic cardiomyopathy: association with late gadolinium enhancement
Stress perfusion CMR in hypertrophic cardiomyopathy: comparison with late gadolinium enhancement
Clinical significance of late gadolinium enhancement in pediatric patients with hypertrophic cardiomyopathy
Ringlike late gadolinium enhancement provides incremental prognostic value in non-classical arrhythmogenic cardiomyopathy
Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
Report of methamphetamine use and cardiomyopathy in three patients
Cardiovascular magnetic resonance imaging characteristics in patients with methamphetamine-associated cardiomyopathy
Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
Methamphetamine induces cardiomyopathy by Sigmar1 inhibition-dependent impairment of mitochondrial dynamics and function
Sex differences in behavior, cognitive, and physiological recovery following methamphetamine administration
Ventricular arrhythmias in apical hypertrophic cardiomyopathy: association with late gadolinium enhancement
Stress perfusion CMR in hypertrophic cardiomyopathy: comparison with late gadolinium enhancement
Clinical significance of late gadolinium enhancement in pediatric patients with hypertrophic cardiomyopathy